A Common Cold Might Set Some Up for Long COVID A Common Cold Might Set Some Up for Long COVID
The research in people with rheumatic diseases could have wider implications, including a blood-based biomarker to predict higher risk.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 22, 2023 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Today's COVID Is Increasingly Looking Like a Cold or Flu
THURSDAY, Sept. 21, 2023 -- Symptoms of mild COVID-19 infection have shifted this season, and now are more akin to those of allergies and the common cold, doctors say.
Many people with COVID-19 now are presenting with upper respiratory symptoms... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 21, 2023 Category: General Medicine Source Type: news
Cold virus may set the stage for Long COVID
Prior infection with a common cold coronavirus may predispose some people to develop Long COVID. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - September 18, 2023 Category: Consumer Health News Source Type: news
Doctors admit they can't tell Covid apart from allergies or the common cold anymore - highlighting how mild virus has become
Patients with the virus are now most likely to suffer from a sore throat, sneezing or congestion - similar to those with RSV , asthma or a pollen allergy. (Source: the Mail online | Health)
Source: the Mail online | Health - September 18, 2023 Category: Consumer Health News Source Type: news
Here ’s Why Many Decongestants May Soon Disappear From Store Shelves
Some of the most common cold medications like Benadryl, Mucinex and variations of Tylenol may soon be forced off shelves after a Food and Drug Administration panel found oral phenylephrine to be ineffective, potentially forcing drug companies to reformulate products and consumers to turn to nasal…#benadryl #mucinex #tylenol #fda #cdc #sudafedpe #dayquil #nyquilseverecold #headache #robitussincough (Source: Reuters: Health)
Source: Reuters: Health - September 12, 2023 Category: Consumer Health News Source Type: news
FDA panel finds an ingredient in cold medications is ineffective
An advisory committee to the U.S. Food and Drug Administration determined Tuesday that an ingredient in common cold medications isn’t effective, raising the possibility that popular decongestants could be removed from the shelves of U.S. stores. Get a curated selection of 10 of our best stories in…#tylenol #fda #mariacoyle (Source: Reuters: Health)
Source: Reuters: Health - September 12, 2023 Category: Consumer Health News Source Type: news
A cold or Pirola - the different symptoms to spot as new Covid variant emerges
Due to the overlap of Omicron symptoms with other respiratory illnesses, Pirola could be similar to the common cold. (Source: Daily Express - Health)
Source: Daily Express - Health - September 8, 2023 Category: Consumer Health News Source Type: news
European Commission approves Roche ’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1Approval is based on interim data from ongoing RAINBOWFISH trial showing majority ofEvrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months ’ treatment2,3Evrysdi is the only non-invasive SMA therapy and is approved in 100 countries with more than 11,000 patients treated globallyBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved the extension of the Evrysdi ® (risdiplam) European Union (EU) marketing ...
Source: Roche Media News - August 29, 2023 Category: Pharmaceuticals Source Type: news
European Commission approves Roche ’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1Approval is based on interim data from ongoing RAINBOWFISH trial showing majority ofEvrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months ’ treatment2,3Evrysdi is the only non-invasive SMA therapy and is approved in 100 countries with more than 11,000 patients treated globallyBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved the extension of the Evrysdi ® (risdiplam) European Union (EU) marketing ...
Source: Roche Investor Update - August 29, 2023 Category: Pharmaceuticals Source Type: news
CHMP recommends Roche ’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
Positive recommendation is based on interim data from ongoing RAINBOWFISH trial which showed majority ofEvrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months ’ treatment1,2If approved by the European Commission,Evrysdi will be available to treat people of all ages with SMA in the European Union, including babies from birthEvrysdi is now approved in 100 countries with more than 8,500 patients treated globallyBasel, 21 July 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the EU Committee for Medicinal Products for Human Use (CHMP) has adopted a positive o...
Source: Roche Media News - July 21, 2023 Category: Pharmaceuticals Source Type: news
CHMP recommends Roche ’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
Positive recommendation is based on interim data from ongoing RAINBOWFISH trial which showed majority ofEvrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months ’ treatment1,2If approved by the European Commission,Evrysdi will be available to treat people of all ages with SMA in the European Union, including babies from birthEvrysdi is now approved in 100 countries with more than 8,500 patients treated globallyBasel, 21 July 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the EU Committee for Medicinal Products for Human Use (CHMP) has adopted a positive o...
Source: Roche Investor Update - July 21, 2023 Category: Pharmaceuticals Source Type: news
This May Be Why Some People Don ’ t Get COVID-19 Symptoms
About three-quarters of people in the U.S. have had COVID-19 at least once, according to the latest federal estimates—but, if they were asymptomatic, some of them might not realize it.
Since the beginning of the pandemic, researchers have tried to understand why some people who are infected by the SARS-CoV-2 virus never experience telltale symptoms like a cough, sore throat, or fever. A new study, published July 19 in Nature, offers one possible explanation: it’s thanks to a quirk of their genes.
Genes that are part of what’s known as the HLA complex help the body identify proteins made by pathogens, such...
Source: TIME: Health - July 19, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Mayo Clinic Minute: What is Takayasu's arteritis?
You've been feeling fatigued, lost a little weight, and had some muscle aches and pains, and your doctor can't determine what's wrong. What seem like symptoms of a common cold could actually be early signs of something called vasculitis, a group of disorders of the blood vessels that often go undiagnosed for years. In this Mayo Clinic Minute, Jason Howland explores one of the rarer forms of vasculitis, Takayasu's arteritis. Watch: The Mayo Clinic Minute… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 18, 2023 Category: Databases & Libraries Source Type: news
What happened to the common cold? Post-Covid, it feels like every sniffle needs a name
Once upon a time, say 2019, scratchy throats and runny noses were expected realities of the common cold — nothing some tissues, Vicks VapoRub and time couldn’t fix. But the pandemic, for better or worse, has fundamentally shifted how we think about respiratory illnesses and the hundreds of viruses…#vicksvaporub #rsv #postcovid #chrischao #raleigh #northcarolina #jasonbae #bae #rhinovirusc #annpalmenberg (Source: Reuters: Health)
Source: Reuters: Health - June 11, 2023 Category: Consumer Health News Source Type: news
What to know about metapneumovirus
If you experienced cough and cold symptoms this spring, you might not have had COVID or the common cold after all. You may have experienced human metapneumovirus—a (relatively) newly recognized “bug” hitting radars in a post-pandemic world. Cases of the virus—discovered in 2001, and also known as…#rsv #georgesbenjamin #fortune #viruses #hmpv #cdc #merckmanual #wash (Source: Reuters: Health)
Source: Reuters: Health - June 1, 2023 Category: Consumer Health News Source Type: news
